Study of the pharmacokinetics and optimal dosage of caspofungin inintensive care patients with a suspected fungal infection.

• Conditions: suspected invasive candidiasis; Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]

• Registration Number: EUCTR2012-003617-34-NL
• Lead Sponsor: niversity Medical Center Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-11-08
• Last Update Posted: 7 December 2015

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Treatment with caspofungin.
Admission to an ICU.
Age = 18 years.
Suspected invasive candidiasis.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40

Exclusion Criteria

Blood sampling not possible.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified